Patents by Inventor Etienne Montagut

Etienne Montagut has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • Risk Stratification
    Publication number: 20180147304
    Abstract: The present invention relates to a method of in vivo imaging with meta-[123I]iodobenzylguanidine ([123I]mIBG) and more particularly wherein said method is used to stratify a defined subset of subjects with heart failure into particular treatment regimens.
    Type: Application
    Filed: May 23, 2016
    Publication date: May 31, 2018
    Applicant: GE HEALTHCARE LIMITED
    Inventors: Jean-Claude Provost, Paul Alexander Jones, Etienne Montagut, Jay Chahal, Meridith Keating Johnson
  • Risk Stratification
    Publication number: 20180147305
    Abstract: The present invention relates to a method of in vivo imaging with meta-[123I]iodobenzylguanidine ([123I]mIBG) and more particularly wherein said method is used to stratify a defined subset of subjects with heart failure into particular treatment regimens.
    Type: Application
    Filed: May 23, 2016
    Publication date: May 31, 2018
    Applicant: GE HEALTHCARE LIMITED
    Inventors: Jean-Claude Provost, Paul Alexander Jones, Etienne Montagut, Jay Chahal, Meridith Keating Johnson